NUCB2 and myeloid sarcoma: To evaluate whether DRN nesfatin-1 is related to the regulation of visceral sensitivity, we observed AWR scores and EMG magnitude in response to graded strengths of CRD pressures in MS rats treated with anti-nesfatin-1/NUCB2 or vehicle.